146 related articles for article (PubMed ID: 31980310)
1. Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14.
Montorsi F; Fossati N; Gandaglia G; Briganti A
Eur Urol; 2020 Apr; 77(4):e107. PubMed ID: 31980310
[No Abstract] [Full Text] [Related]
2. Reply to Pablo Sierra's Letter to the Editor re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14.
Preisser F; Tilki D
Eur Urol; 2019 Aug; 76(2):e42. PubMed ID: 31060821
[No Abstract] [Full Text] [Related]
3. Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14: Useful Prognostic Information in Prostate Cancer After Radical Prostatectomy Might Not Be Applicable to High-risk Disease.
Sierra PS
Eur Urol; 2019 Aug; 76(2):e41. PubMed ID: 31064693
[No Abstract] [Full Text] [Related]
4. Reply to Jae Heon Kim, Bora Lee, and Benjamin I. Chung's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50.
Mandel P; Tilki D
Eur Urol; 2017 Dec; 72(6):e176. PubMed ID: 28709729
[No Abstract] [Full Text] [Related]
5. Reply to Paolo Capogrosso, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50. Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment?
Mandel P; Graefen M; Huland H; Tilki D
Eur Urol; 2017 Dec; 72(6):e179. PubMed ID: 28712858
[No Abstract] [Full Text] [Related]
6. Re: Felix K.-H. Chun, Thomas Steuber, Andreas Erbersdobler, et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49:820-26.
Beckley I; Khan MA
Eur Urol; 2007 Oct; 52(4):1270; author reply 1271. PubMed ID: 17611016
[No Abstract] [Full Text] [Related]
7. Re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50.
Kim JH; Lee B; Chung BI
Eur Urol; 2017 Dec; 72(6):e175. PubMed ID: 28709728
[No Abstract] [Full Text] [Related]
8. Re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50: Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment?
Capogrosso P; Montorsi F; Salonia A
Eur Urol; 2017 Dec; 72(6):e177-e178. PubMed ID: 28716369
[No Abstract] [Full Text] [Related]
9. Re: Alberto Briganti, Umberto Capitanio, Felix K.-H. Chun, et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urol 2008;54:794-804.
Bogdanovic J; Sekulic V
Eur Urol; 2008 Oct; 54(4):955-6. PubMed ID: 18687518
[No Abstract] [Full Text] [Related]
10. Re: Alberto Briganti, Umberto Capitanio, Felix K.-H. Chun, et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urol 2008;54:794-804.
Cai T; Nesi G; Bartoletti R
Eur Urol; 2009 Feb; 55(2):e32-3; author reply e34-5. PubMed ID: 18760527
[No Abstract] [Full Text] [Related]
11. Re: Giorgio Gandaglia, Carlo Andrea Bravi, Paolo Dell'Oglio, et al. The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy. Eur Urol 2018;74:4-7.
Bertolo R
Eur Urol; 2018 Nov; 74(5):e114-e115. PubMed ID: 30017398
[No Abstract] [Full Text] [Related]
12. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7. Re: Ronald C. Chen. Postprostatectomy Radiotherapy: Whether and How Long to Give Concurrent Androgen Deprivation Therapy. Eur Urol 2016;69:58-9: Which patients need treatment intensification?
Dal Pra A; Spahn M
Eur Urol; 2016 Apr; 69(4):e74-e75. PubMed ID: 26508311
[No Abstract] [Full Text] [Related]
13. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
Temiz MZ; Besiroglu H
Eur Urol; 2018 May; 73(5):e130. PubMed ID: 29397220
[No Abstract] [Full Text] [Related]
14. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
Dal Pra A; Supiot S; Ghadjar P
Eur Urol; 2018 Feb; 73(2):e34-e35. PubMed ID: 28890243
[No Abstract] [Full Text] [Related]
15. Re: Karim A. Touijer, Robert Jeffery Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.
van Leeuwen PJ; van der Poel HG
Eur Urol; 2018 Jul; 74(1):e15-e17. PubMed ID: 29661485
[No Abstract] [Full Text] [Related]
16. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7.
Hu YW
Eur Urol; 2016 Dec; 70(6):e158. PubMed ID: 27166669
[No Abstract] [Full Text] [Related]
17. Re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol Focus. 2023;9:309-16.
Rocco B; Sighinolfi MC
Eur Urol Focus; 2023 May; 9(3):547. PubMed ID: 36411205
[No Abstract] [Full Text] [Related]
18. Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44.
Torricelli FCM; Coelho RF
Eur Urol; 2021 Aug; 80(2):e57. PubMed ID: 34099342
[No Abstract] [Full Text] [Related]
19. Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44.
Pfister D; Hartmann F; Heidenreich A
Eur Urol; 2021 Aug; 80(2):e61. PubMed ID: 34023162
[No Abstract] [Full Text] [Related]
20. Re: Giorgio Guazzoni, Massimo Lazzeri, Luciano Nava, et al. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Eur Urol 2012;61:455-66.
Tadtayev S; McNicholas TA; Boustead GB
Eur Urol; 2012 Jul; 62(1):e14-5; author reply e16-7. PubMed ID: 22537798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
